Vesuvius plc (VSVS.L) Bundle
Dive into Vesuvius plc's H1 2025 performance where revenue held fairly steady at £907.5m (underlying -0.4% vs H1 2024) even as trading profit fell to £77m (underlying -16.1%) and RoS compressed to 8.5%; the group offset some pressure with market share gains across all regions and a stronger Steel RoS of 11.4%, while Foundry declined. Balance sheet and liquidity snapshots reveal net debt rising to £452.4m (net debt/EBITDA 2.0x) alongside a current ratio of 2.03, committed facilities of £761.2m (£238.5m undrawn) and the €26.2m acquisition of a 61.65% stake in PiroMET; cash flow dynamics were challenged with adjusted operating cash flow of £25.8m and free cash flow outflow of £12.6m in H1. Valuation and upside figures to watch include analyst 2025 revenue consensus of £1.8bn, a consensus price target of 467.50p (~21% upside), a P/E of 10.48, ~£1.5bn market cap and a c.3.5% dividend yield, while management targets £45m of annual cost savings by 2028 and expects second-half 2025 performance broadly in line with H1 as it navigates persistent regional weakness.
Vesuvius plc (VSVS.L) - Revenue Analysis
Vesuvius plc reported H1 2025 revenue of £907.5 million, representing an underlying decline of 0.4% versus H1 2024. This outcome reflects broadly stable sales in a period of uneven end-market demand, with market-share gains offsetting pockets of weakness.- H1 2025 reported revenue: £907.5m (underlying -0.4% vs H1 2024)
- Market-share performance: strong gains across all regions
- Near-term outlook: challenging conditions expected to persist through remainder of 2025, particularly in Europe
- Guidance: management expects H2 2025 performance to be broadly in line with H1, with improvements anticipated in 2026
| Metric/Segment | H1 2025 | YoY Change (Underlying) | Notes |
|---|---|---|---|
| Total revenue | £907.5m | -0.4% | Stable sales, offsetting weaker pockets |
| Foundry Division revenue | - (reported decline) | -3.1% | Weakened markets outside India drove the decline |
| Steel Division revenue | - (positive net pricing) | Positive (net pricing maintained) | Robust pricing contributed to division performance |
| Regional performance | All regions | Market-share gains | Strong share gains across Europe, Americas, Asia |
| Outlook for remainder of 2025 | Flat vs H1 | - | Challenging, especially in Europe; improvements expected in 2026 |
- Foundry: -3.1% YoY driven by external demand weakness outside India; India remained a relative stabilizer.
- Steel: maintained positive net pricing across the portfolio, supporting margin resilience despite volume pressure.
- Market-share gains: execution and aftermarket strength enabled share capture across regions, helping offset revenue softness.
Vesuvius plc (VSVS.L) - Profitability Metrics
Vesuvius reported mixed profitability performance in H1 2025 as higher input and labour costs weighed on group margins while divisional dynamics diverged.- Trading profit H1 2025: £77.0m (underlying decline of 16.1% vs H1 2024)
- Group Return on Sales (RoS) H1 2025: 8.5% (down 160bps on an underlying basis)
- Steel Division RoS H1 2025: 11.4% (up 110bps on an underlying basis)
- Foundry Division RoS H1 2025: 7.4% (down 230bps on an underlying basis)
- Targeted cost reductions: £45m annual run-rate savings by 2028
- 2025 trading profit guidance: broadly similar to 2024 on a constant currency basis, including PiroMET contribution
| Metric | H1 2025 | Underlying change vs H1 2024 |
|---|---|---|
| Trading profit | £77.0m | -16.1% |
| Group RoS | 8.5% | -160 bps |
| Steel Division RoS | 11.4% | +110 bps |
| Foundry Division RoS | 7.4% | -230 bps |
| Cost reduction target | £45m pa by 2028 | - |
| 2025 trading profit outlook | Broadly similar to 2024 (constant currency) | Includes PiroMET |
- Margin compression at group level primarily from increased raw material and labour costs, pressuring RoS by 160bps.
- Steel Division outperformance-RoS up 110bps-attributable to realised cost savings and positive net pricing recovery.
- Foundry Division underperformance-RoS down 230bps-reflects low activity in key end markets and softer volumes, requiring margin rescue measures.
- £45m cost programme intended to restore medium-term profitability; the timing of full benefit is through to 2028.
- Management expects 2025 trading profit broadly stable year-on-year on a constant currency basis, with acquisitions (PiroMET) factored into the outlook.
Vesuvius plc (VSVS.L) - Debt vs. Equity Structure
Vesuvius plc's balance between debt and equity shifted through H1 2025 as strategic investments and free cash flow outflows increased leverage while management maintained committed facilities to preserve flexibility.| Metric | 30 Jun 2025 | 31 Dec 2024 |
|---|---|---|
| Net debt | £452.4m | £329.2m |
| Net debt / EBITDA | 2.0x | 1.3x |
| EBITDA / Interest | 15.0x | 18.4x |
| Committed borrowing facilities (total) | £761.2m | - |
| Undrawn facilities | £238.5m | - |
| New syndicated facility (signed Feb 2025) | £475.0m (matures Aug 2029) | Previous: £385.0m |
| Acquisition - PiroMET stake (Feb 2025) | 61.65% for €26.2m | - |
- Net debt increased by £123.2m from Dec 2024 to Jun 2025, driven by free cash flow outflows and strategic investments (notably PiroMET).
- Leverage moved to 2.0x net debt/EBITDA, reflecting a higher reliance on debt relative to earnings versus 1.3x at end-2024.
- Interest coverage remains strong at 15.0x EBITDA/interest, though reduced from 18.4x - still indicative of comfortable serviceability.
- Committed facilities of £761.2m, with £238.5m undrawn, provide liquidity headroom for operations and M&A.
- The new £475m syndicated facility (Feb 2025) extends debt maturity to Aug 2029 and replaced the prior £385m facility, improving covenant runway.
- Strategic allocation: cash outflows toward the €26.2m PiroMET acquisition (61.65% stake) support growth in EEMEA but temporarily elevate net leverage.
- Liquidity mix: committed facilities plus undrawn amounts give Vesuvius the ability to manage working capital, refinance risk, and fund further targeted investments.
- Coverage and covenant profile: despite higher net debt, EBITDA/interest of 15.0x and the syndicated facility structure suggest low near-term refinancing stress.
Vesuvius plc (VSVS.L) - Liquidity and Solvency
Vesuvius's liquidity profile at 30 June 2025 shows overall robustness but with clear near-term cash-flow pressure driven by working capital and capex. Key headline metrics and recent developments are summarized below.- Current ratio (30 June 2025): 2.03 - indicates ample short-term liquidity to cover current liabilities.
- Adjusted operating cash flow (H1 2025): £25.8m, down 46.1% vs H1 2024 - reflects higher working capital requirements.
- Free cash flow (H1 2025): outflow of £12.6m vs inflow £17.8m in H1 2024 - impacted by increased capex and working capital investments.
- Trade working capital intensity (30 June 2025): 23.5% vs 23.2% (30 June 2024) - broadly stable, slight increase.
- Committed borrowing facilities (30 June 2025): £761.2m total, £238.5m undrawn - provides liquidity headroom and financing flexibility.
- Strategic acquisition: 61.65% stake in PiroMET for €26.2m completed in February 2025 - strengthens EEMEA position and has near-term cash implications.
| Metric | H1 2025 | H1 2024 / 30 Jun 2024 | Comment |
|---|---|---|---|
| Current ratio (30 Jun) | 2.03 | - | Healthy short-term coverage |
| Adjusted operating cash flow | £25.8m | £47.8m | 46.1% decline due to working capital build |
| Free cash flow | £(12.6)m | £17.8m | Shift to outflow from higher capex & working capital |
| Trade working capital intensity | 23.5% | 23.2% | Marginal increase; management controlling inventory/receivables |
| Committed borrowing facilities | £761.2m (total) | - | £238.5m undrawn - liquidity cushion |
| Material acquisition | 61.65% of PiroMET (€26.2m) | - | Enhances EEMEA footprint; uses cash/financing |
- Operational impact: reduced operating cash conversion in H1 2025 increases reliance on committed facilities and available cash.
- Solvency considerations: with significant undrawn facilities and a >2.0 current ratio, solvency risk remains limited absent large unforeseen shocks.
- Working capital management: slight rise in trade WC intensity warrants monitoring but is not yet a structural concern.
- Capital allocation: acquisition of PiroMET strengthens strategic positioning but contributed to H1 cash outflow - track integration benefits versus near-term liquidity strain.
Vesuvius plc (VSVS.L) Valuation Analysis
Key valuation metrics and projections for Vesuvius plc highlight a mid-cap industrial with value characteristics, an income component, and moderate leverage. Analysts project revenue growth into 2025, and recent corporate actions aim to bolster future earnings.
| Metric | Value |
|---|---|
| 2025 Revenue (analyst consensus) | £1.8 billion |
| Consensus price target | 467.50p (≈21% upside) |
| Current P/E ratio | 10.48 |
| Market capitalisation | ≈ £1.5 billion |
| Dividend yield | ~3.5% |
| Net debt / EBITDA | 2.0x |
| Recent acquisition | PiroMET |
- Revenue outlook: Analysts expect £1.8bn in 2025, supporting upside to earnings forecasts if margins hold or improve post-integration of PiroMET.
- Valuation multiple: A P/E of 10.48 is below many peers in industrial materials, suggesting potential value if growth materialises.
- Capital structure: Net debt/EBITDA of 2.0x reflects moderate leverage - manageable but a factor in risk-adjusted valuation.
- Income profile: A c.3.5% yield enhances the total return case for income-focused investors.
- M&A impact: The PiroMET acquisition is expected to be earnings-accretive, which could justify a re-rating if synergies and margin expansion are realised.
Investor considerations include sensitivity to cyclicality in steel and foundry end markets, potential margin recovery, and successful integration of PiroMET to convert revenue growth into EPS. For more on shareholder composition and buying rationale, see: Exploring Vesuvius plc Investor Profile: Who's Buying and Why?
Vesuvius plc (VSVS.L) - Risk Factors
Vesuvius faces a set of interrelated risks that materially affect revenue, margins and cash generation. The following outlines the principal exposures, their potential financial impact, and measurable indicators investors should monitor.- Persistent demand weakness across key regions (Europe, North America, China): sustained softness can reduce top-line and operating leverage.
- Geopolitical volatility and shifting trade tariffs: changes to tariffs or export controls could raise cost of goods sold (COGS) and disrupt sales into targeted markets.
- Pricing pressure limits recovery of labor cost inflation: inability to fully pass through wage inflation squeezes operating margins, particularly in Europe and China where price elasticity is higher.
- Integration risks from the PiroMET acquisition: delayed synergies, integration costs, or customer churn could reduce expected EBITDA uplift.
- Raw material and labor cost volatility: swings in energy, refractory raw materials and regional labor markets can compress gross and EBITDA margins.
- Regulatory and environmental policy changes: tighter emissions, waste or industrial compliance rules can require capital expenditure and raise ongoing compliance costs.
| Risk | Key Financial Metric Affected | Example Near‑Term Impact (Illustrative) |
|---|---|---|
| Weak regional demand | Revenue | Revenue decline of 5-12% in a sustained slowdown scenario; FY revenue moved from ~£1.6bn to ~£1.4bn (-12%) in stress case |
| Tariff/geopolitical shocks | COGS / Gross margin | COGS increase by 2-5 percentage points, reducing gross margin by the same magnitude |
| Labor cost inflation | EBITDA margin | Wage inflation recovery gap could cut adjusted EBITDA margin by 1-3 ppt |
| PiroMET integration | Synergy realization / Net debt | Delay of £10-30m in annual synergies; one‑off integration costs of £5-15m; potential temporary net debt rise |
| Raw material volatility | Operating margin | Commodity-driven margin swings of ±1-4 ppt depending on pass-through |
| Regulatory compliance | CapEx / Opex | Incremental annual compliance costs of £5-25m; discrete capex of £10-50m over 3 years in stringent scenarios |
- Quarterly revenue growth by region (Europe, North America, China) and order intake trends.
- Gross margin and adjusted EBITDA margin movements vs. prior-year and guidance.
- Net debt / adjusted EBITDA leverage ratio - watch for expansion above covenant thresholds (e.g., >2.5-3.0x depending on facilities).
- Progress versus announced PiroMET synergy targets (amounts and timing) and any disclosed integration costs.
- Realized pricing vs. input cost inflation (labor, energy, refractory feedstocks) - monitored as basis points of margin erosion or recovery.
- Capital expenditure and environmental provision changes disclosed in interim and annual reports.
| Scenario | Revenue change | Adj. EBITDA margin change | Net debt delta |
|---|---|---|---|
| Base | 0% y/y | ~8-10% (company baseline) | Stable / minor fluctuation (~±£20m) |
| Moderate downside | -6% y/y | -1.5 ppt | +£30-70m (temporary to cover working capital) |
| Severe downside | -12% y/y | -3.0-4.0 ppt | +£80-150m (potential covenant pressure) |
- Compare quarterly organic revenue by region to prior year and management guidance.
- Track raw material indices and published labor-cost trends in key manufacturing geographies.
- Review management commentary on pricing actions and recovery of input inflation.
- Assess PiroMET integration KPI disclosures: realized synergies, headcount changes, and one-off costs.
- Watch net debt movement, covenant tests, and any change in bank facility terms.
- Follow regulatory announcements affecting refractory and foundry industries and disclosed environmental provisions.
Vesuvius plc (VSVS.L) - Growth Opportunities
Vesuvius plc (VSVS.L) is leveraging strategic M&A, cost reduction, R&D investment and capacity expansion to drive medium‑term growth, margin improvement and cash generation.
- PiroMET acquisition strengthens EEMEA presence and adds capabilities across refractories and robotics, increasing addressable market exposure in steel and foundry segments.
- Cost reduction program targeting £45 million of annual savings by 2028 to materially lift operating margin and cash flow conversion.
- R&D investment of £37 million in 2024 to support new product development, process automation and digital service offerings.
- Focused expansion across Asia and Flow Control to access faster‑growing end markets and diversify geographic revenue mix.
- Market share initiatives across all regions designed to convert share gains into sustainable top‑line growth.
- Completion of the capacity investment program positioned to enhance free cash flow generation and accelerate deleveraging.
| Growth Lever | Key Metric / Target | Expected Impact |
|---|---|---|
| PiroMET acquisition (EEMEA) | Acquisition completed - expands refractory & robotics capability | Greater market penetration in EEMEA; cross‑sell opportunities |
| Cost reduction program | £45 million annual savings by 2028 | Improved EBITDA margin and incremental free cash flow |
| R&D spend | £37 million in 2024 | New product pipeline, digital & automation enhancements |
| Geographic & segment expansion | Asia & Flow Control strategic initiatives (Ongoing) | Access to higher‑growth end markets and revenue diversification |
| Capacity investment completion | Program nearing completion (capex phased completion) | Higher throughput, improved unit economics, stronger FCF |
Key tactical implications for investors include prioritizing the trajectory of cost‑savings realization, monitoring commercialization outcomes from the £37 million R&D pipeline, and tracking incremental free cash flow as capacity investments come online. For contextual background on the company's strategy and structure, see Vesuvius plc: History, Ownership, Mission, How It Works & Makes Money.

Vesuvius plc (VSVS.L) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.